Fei Tong

500 total citations
27 papers, 331 citations indexed

About

Fei Tong is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Fei Tong has authored 27 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Cancer Research and 5 papers in Surgery. Recurrent topics in Fei Tong's work include MicroRNA in disease regulation (6 papers), Orthodontics and Dentofacial Orthopedics (4 papers) and Paraquat toxicity studies and treatments (4 papers). Fei Tong is often cited by papers focused on MicroRNA in disease regulation (6 papers), Orthodontics and Dentofacial Orthopedics (4 papers) and Paraquat toxicity studies and treatments (4 papers). Fei Tong collaborates with scholars based in China, United Kingdom and Portugal. Fei Tong's co-authors include Qixue Wang, Chunsheng Kang, Jixing Zhao, Yanli Tan, Eryan Yang, Jun Shen, Yiming Zhong, Yunfei Wang, Junhu Zhou and Xiaoteng Cui and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease and Theranostics.

In The Last Decade

Fei Tong

26 papers receiving 327 citations

Peers

Fei Tong

GENET

PRM

ONCOL

Yonggang Wang China

Hanna Göransson Kultima Sweden

Zhiyong Qin China

Chaoying Qin China

Ruizhe Zhu China

Omanma Adighibe United Kingdom

Qungen Xiao China

Yin-sheng Chen China

Yonggang Wang China

Fei Tong

116 ×0.7

132 ×1.1

128 ×2.4

GENET

62 ×1.3

PRM

59 ×1.3

ONCOL

Citations per year, relative to Fei Tong Fei Tong (= 1×) peers Yonggang Wang

Countries citing papers authored by Fei Tong

Since Specialization

Citations

This map shows the geographic impact of Fei Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Tong more than expected).

Fields of papers citing papers by Fei Tong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Tong. The network helps show where Fei Tong may publish in the future.

Co-authorship network of co-authors of Fei Tong

This figure shows the co-authorship network connecting the top 25 collaborators of Fei Tong. A scholar is included among the top collaborators of Fei Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Tong. Fei Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Long, Gen, Fen Liu, Jun Guo, et al.. (2025). miR-374-5p inhibits osteogenesis by targeting PTEN/PI3K/AKT signaling pathway. Journal of Orthopaedic Surgery and Research. 20(1). 283–283. 1 indexed citations

Jiang, Qianqian, et al.. (2024). Cuproptosis: a promising new target for breast cancer therapy. Cancer Cell International. 24(1). 414–414. 1 indexed citations

Tong, Fei, Yi Lu, Hongfang Ma, & Jun Shen. (2024). Comparative efficacy and safety of CDK4/6 inhibitors combined with endocrine therapies for HR+/HER2-breast cancer: Systematic review and network meta-analysis. Heliyon. 10(11). e31583–e31583. 5 indexed citations

Al-Ak’hali, Mohammed Sultan, Esam Halboub, Fei Tong, et al.. (2024). The relationship between the dimensions of frontal air sinus and skeletal malocclusions: A systematic review and meta-analysis. Heliyon. 10(2). e24200–e24200. 1 indexed citations

Cui, Xiaoteng, Jixing Zhao, Guanzhang Li, et al.. (2023). Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma. Cancer Communications. 43(12). 1326–1353. 22 indexed citations

Wang, Pei, et al.. (2023). Developing a Novel Enamel Adhesive with Amorphous Calcium Phosphate and Silver Nanoparticles to Prevent Demineralization during Orthodontic Treatment. Journal of Functional Biomaterials. 14(2). 77–77. 12 indexed citations

Pan, Zhicheng, Yun Xiao, Fei Tong, et al.. (2023). MiR-934 Exacerbates Malignancy of Gastric Cancer Cells by Targeting ZFP36. Iranian Journal of Public Health. 52(8). 1720–1729. 3 indexed citations

Tong, Fei, et al.. (2023). Treatment of a severe skeletal Class II malocclusion through growth modification: a problem-oriented case report. Australasian Orthodontic Journal. 39(2). 82–95. 1 indexed citations

Zhou, Junhu, Fei Tong, Jixing Zhao, et al.. (2023). Identification of the E2F1-RAD51AP1 axis as a key factor in MGMT-methylated GBM TMZ resistance. Cancer Biology and Medicine. 20(5). 385–400. 11 indexed citations

10.

Tong, Fei, et al.. (2023). MiR-466d Targeting MMP13 Promotes the Differentiation of Osteoblasts Exposed to a Static Magnetic Field. Biotechnology and Bioprocess Engineering. 28(1). 91–100.

11.

Zhong, Yiming, Fei Tong, & Jun Shen. (2022). Lympho-vascular invasion impacts the prognosis in breast-conserving surgery: a systematic review and meta-analysis. BMC Cancer. 22(1). 102–102. 32 indexed citations

12.

Yang, Eryan, Lin Wang, Weili Jin, et al.. (2022). PTRF/Cavin-1 enhances chemo-resistance and promotes temozolomide efflux through extracellular vesicles in glioblastoma. Theranostics. 12(9). 4330–4347. 27 indexed citations

13.

Zhang, Manli, Manna Zhang, Wenli Wang, et al.. (2022). 17β-estradiol reduces NF-κB expression induced by increased crosstalk between KLF5 and ERα in murine vascular smooth muscle cells. Biochemical and Biophysical Research Communications. 625. 181–187. 3 indexed citations

14.

Jin, Weili, Jixing Zhao, Eryan Yang, et al.. (2022). Neuronal STAT3/HIF-1α/PTRF axis-mediated bioenergetic disturbance exacerbates cerebral ischemia-reperfusion injury via PLA2G4A. Theranostics. 12(7). 3196–3216. 61 indexed citations

15.

Zhao, Ziyi, et al.. (2021). Review of applications of CRISPR-Cas9 gene-editing technology in cancer research. Biological Procedures Online. 23(1). 14–14. 26 indexed citations

16.

Tong, Fei, et al.. (2020). Treatment and posttreatment effects of a novel magnetic palatal expansion appliance with reactivation system in dogs. American Journal of Orthodontics and Dentofacial Orthopedics. 157(2). 194–204. 3 indexed citations

17.

Tong, Fei, et al.. (2020). LncRNA SNHG17 promotes the progression of oral squamous cell carcinoma by modulating miR-375/PAX6 axis. Cancer Biomarkers. 30(1). 1–12. 19 indexed citations

18.

Zhang, Manli, Bin Zheng, Fei Tong, et al.. (2017). iNOS-derived peroxynitrite mediates high glucose-induced inflammatory gene expression in vascular smooth muscle cells through promoting KLF5 expression and nitration. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1863(11). 2821–2834. 28 indexed citations

19.

Tong, Fei, et al.. (2016). Effects of a magnetic palatal expansion appliance with reactivation system: An animal experiment. American Journal of Orthodontics and Dentofacial Orthopedics. 151(1). 132–142. 3 indexed citations

20.

Zhou, Lv, Zelin Liu, Jinping Hu, et al.. (2016). Cutaneous clear cell/signet-ring cell squamous cell carcinoma arising in the right thigh of a patient with type 2 diabetes: combined morphologic, immunohistochemical, and etiologic analysis. Diagnostic Pathology. 11(1). 36–36. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact